HomeFULC • NASDAQ
add
Fulcrum Therapeutics Inc
Previous close
$2.97
Day range
$2.95 - $3.30
Year range
$2.87 - $13.70
Market cap
202.80M USD
Avg Volume
762.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.42M | -15.43% |
Net income | -21.70M | 9.66% |
Net profit margin | — | — |
Earnings per share | -0.46 | -18.79% |
EBITDA | -22.69M | 15.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 257.23M | 0.06% |
Total assets | 279.01M | 0.05% |
Total liabilities | 21.72M | -7.26% |
Total equity | 257.29M | — |
Shares outstanding | 53.94M | — |
Price to book | 0.62 | — |
Return on assets | -20.12% | — |
Return on capital | -20.97% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -21.70M | 9.66% |
Cash from operations | -19.07M | 16.74% |
Cash from investing | 4.35M | -77.13% |
Cash from financing | 635.00K | — |
Net change in cash | -14.09M | -262.51% |
Free cash flow | -12.24M | 13.43% |
About
Founded
2015
Website
Employees
76
